McKesson stock: UBS lifts target for McKesson stock to USD 1,200.00

Published on 10/19/2026 at 16:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Market capitalization stood at USD 116.8 billion on October 19, 2026. McKesson stock costs EUR 895.20 on October 19, 2026 at 4:09 p.m. CEST.

Analyst target and valuation

UBS raised its McKesson target from USD 1,080.00 to USD 1,200.00 on October 16, 2026.
McKesson's market capitalization was USD 116.8 billion on October 19, 2026.
McKesson stock costs EUR 895.20 at Lang & Schwarz on October 19, 2026 at 4:09 p.m. CEST.
The stock's price-to-earnings ratio was 26.79 and its dividend yield was 0.00 percent on October 19, 2026.

Trader auf Börsenparkett vor Bildschirmen mit Kurscharts und Gesundheitsdaten — Börsen-Editorial-Foto vom Trading-Floor mit Charts symbolisiert Börsennotierung von McKesson Corporation ISIN US58155Q1031 an der NYSE, Illustration mit AI erstellt.

UBS raised its McKesson target from USD 1,080.00 to USD 1,200.00 on October 16, 2026, while retaining a Buy rating, according to Markets Insider. Against the USD 1,001.45 primary-exchange price, the new target stands 19.83 percent higher. McKesson was trading at EUR 895.20 at Lang & Schwarz on October 19, 2026 at 4:09 p.m. CEST.

Market value reaches USD 116.8 billion

McKesson's market capitalization was USD 116.8 billion on October 19, 2026. The primary listing is on the NYSE, where the stock was last at USD 1,001.45 on October 19, 2026 at 10:20 a.m. ET. The 52-week range was USD 723.68 to USD 1,014.99, placing the primary-exchange price 1.34 percent below the high.

Price position and trading range

The euro quotation gives German investors a separate trading view of the same company. The Lang & Schwarz bid was EUR 892.80 and the ask was EUR 897.60 on October 19, 2026. The quoted range is wider than the 52-week distance, so the analyst target remains the clearer valuation reference in this report.

McKesson reported USD 105.38 billion in revenue for the first quarter of fiscal 2027, with diluted earnings per share of USD 5.15. Net income attributable to common shareholders was USD 614.0 million for that period. These figures provide the latest operating backdrop for the target revision.

Valuation and peer comparison

The price-to-earnings ratio was 26.79 and the dividend yield was 0.00 percent on October 19, 2026. McKesson's average volume was 896,959 shares, against 85,175 shares traded at the recorded primary-exchange timestamp.

Comparison with peers

McKesson (NYSE, USD): price-to-earnings ratio 26.79, market capitalization USD 116.8 billion.

Cencora (NYSE, USD): minus 0.28 percent, price-to-earnings ratio 25.26, market capitalization USD 64.9 billion.

Cardinal Health (NYSE, USD): minus 1.02 percent, price-to-earnings ratio 34.82, market capitalization USD 58.2 billion.

Investor reference points

For investors, the key distinction is between the upgraded USD 1,200.00 target and the current USD 1,001.45 primary-exchange quotation. The latest fiscal-quarter revenue figure also gives the target revision an operating reference, while the zero dividend yield keeps the valuation discussion focused on earnings and price appreciation rather than income.

McKesson was trading at EUR 895.20 at Lang & Schwarz on October 19, 2026 at 4:09 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of McKesson stock.